Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

USA - NASDAQ:AIRS - US0094961002 - Common Stock

8.55 USD
+0.52 (+6.48%)
Last: 10/8/2025, 8:27:03 PM
8.6101 USD
+0.06 (+0.7%)
After Hours: 10/8/2025, 8:27:03 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AIRS. AIRS was compared to 101 industry peers in the Health Care Providers & Services industry. AIRS may be in some trouble as it scores bad on both profitability and health. AIRS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AIRS has reported negative net income.
AIRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AIRS reported negative net income in multiple years.
AIRS had a positive operating cash flow in each of the past 5 years.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of AIRS (-7.32%) is worse than 72.28% of its industry peers.
Looking at the Return On Equity, with a value of -15.92%, AIRS is doing worse than 65.35% of the companies in the same industry.
Industry RankSector Rank
ROA -7.32%
ROE -15.92%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With an excellent Gross Margin value of 63.26%, AIRS belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
AIRS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AIRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AIRS has more shares outstanding
AIRS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AIRS is higher compared to a year ago.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

AIRS has an Altman-Z score of 3.22. This indicates that AIRS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.22, AIRS is doing good in the industry, outperforming 65.35% of the companies in the same industry.
A Debt/Equity ratio of 0.58 indicates that AIRS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, AIRS is in line with its industry, outperforming 58.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 3.22
ROIC/WACCN/A
WACC9.21%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

AIRS has a Current Ratio of 0.64. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of AIRS (0.64) is worse than 89.11% of its industry peers.
A Quick Ratio of 0.64 indicates that AIRS may have some problems paying its short term obligations.
AIRS's Quick ratio of 0.64 is on the low side compared to the rest of the industry. AIRS is outperformed by 85.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AIRS have decreased strongly by -171.43% in the last year.
AIRS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.46%.
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 34.35% on average per year.
EPS 1Y (TTM)-171.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-13.71%

3.2 Future

AIRS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.70% yearly.
Based on estimates for the next years, AIRS will show a small growth in Revenue. The Revenue will grow by 3.40% on average per year.
EPS Next Y86.4%
EPS Next 2Y48.46%
EPS Next 3Y35.7%
EPS Next 5YN/A
Revenue Next Year-11.71%
Revenue Next 2Y-3.66%
Revenue Next 3Y0.44%
Revenue Next 5Y3.4%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AIRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AIRS is valuated quite expensively with a Price/Forward Earnings ratio of 279.41.
AIRS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AIRS is more expensive than 62.38% of the companies in the same industry.
AIRS is valuated expensively when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 279.41
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AIRS indicates a slightly more expensive valuation: AIRS is more expensive than 64.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 132.57
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AIRS's earnings are expected to grow with 35.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.46%
EPS Next 3Y35.7%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (10/8/2025, 8:27:03 PM)

After market: 8.6101 +0.06 (+0.7%)

8.55

+0.52 (+6.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners28.04%
Inst Owner Change0%
Ins Owners26.16%
Ins Owner Change1.01%
Market Cap533.86M
Analysts76
Price Target6.12 (-28.42%)
Short Float %37.65%
Short Ratio7.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)157.21%
Min EPS beat(2)67.32%
Max EPS beat(2)247.1%
EPS beat(4)2
Avg EPS beat(4)28.68%
Min EPS beat(4)-103.64%
Max EPS beat(4)247.1%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)4
Avg EPS beat(12)-90.01%
EPS beat(16)5
Avg EPS beat(16)-82.21%
Revenue beat(2)0
Avg Revenue beat(2)-3.35%
Min Revenue beat(2)-5.06%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-4.55%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-4.25%
Revenue beat(12)2
Avg Revenue beat(12)-3.82%
Revenue beat(16)5
Avg Revenue beat(16)-1.75%
PT rev (1m)0%
PT rev (3m)26.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)39.99%
EPS NY rev (1m)57.15%
EPS NY rev (3m)84.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 279.41
P/S 3.23
P/FCF N/A
P/OCF 51.36
P/B 5.86
P/tB N/A
EV/EBITDA 132.57
EPS(TTM)-0.19
EYN/A
EPS(NY)0.03
Fwd EY0.36%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.17
OCFY1.95%
SpS2.64
BVpS1.46
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.32%
ROE -15.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.26%
FCFM N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 12.8
Cap/Depr 83.5%
Cap/Sales 6.42%
Interest Coverage N/A
Cash Conversion 250.12%
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z 3.22
F-Score3
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-171.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next Y86.4%
EPS Next 2Y48.46%
EPS Next 3Y35.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.46%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-13.71%
Revenue Next Year-11.71%
Revenue Next 2Y-3.66%
Revenue Next 3Y0.44%
Revenue Next 5Y3.4%
EBIT growth 1Y-201.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year34.56%
EBIT Next 3Y20.93%
EBIT Next 5YN/A
FCF growth 1Y-101.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.12%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%